QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module VII: PSUR Assessment, PRAC and Regulatory Follow-Up Knowledge Assessment

Test your understanding of the concepts covered by GVP Module VII: PSUR Assessment, PRAC and Regulatory Follow-Up.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate regulatory-intelligence response when EMA procedural guidance changes?

Archive the updated guidance without further action Apply the change retrospectively to every closed procedure Assess the change for operational impact and update relevant processes or controls where necessary Wait for an inspection finding before evaluating the change

Question 2 of 10 Which statement most accurately characterises the assessor's core question during PSUR review?

Whether the PSUR contains the maximum possible number of safety cases Whether the document is internally consistent, regardless of benefit-risk implications Whether the evidence changes understanding of the benefit-risk balance and what regulatory response is appropriate Whether the MAH has reached the same conclusion as other MAHs

Question 3 of 10 A variation submission implementing a PSUSA outcome has been filed. What additional control is most important before closing the implementation action?

Delete the preliminary assessment report from the records Verify the authorised wording and its implementation in all relevant products, markets, systems and controlled materials Assume that submission guarantees correct implementation Wait for the next PSUR without reviewing the approved wording

Question 4 of 10 Which statement correctly distinguishes implementation from effectiveness of a risk-minimisation measure?

Once a measure is implemented, its effectiveness is established Implementation shows that the measure was put in place; effectiveness requires evidence that it achieved its intended clinical purpose Effectiveness can be assessed without confirming whether the measure was implemented Neither implementation nor effectiveness needs to be documented after a maintenance outcome

Question 5 of 10 Why should cumulative evidence be considered rather than focusing only on the newest reporting-interval data?

The latest reporting interval is never scientifically relevant A new observation may gain or lose significance when interpreted with the previous evidence and overall trajectory Cumulative evidence is used only for administrative filing Only historical cases can support regulatory action

Question 6 of 10 What is the main value of maintaining a complete PSUSA regulatory evidence trail?

It demonstrates only that documents were stored in chronological order It allows the organisation to reconstruct what was known, concluded, required and verified across the procedure and follow-up It eliminates the need for scientific review of future PSURs It proves that the MAH and regulator always reached the same conclusion

Question 7 of 10 An assessor asks for clarification because the submitted evidence is insufficient to evaluate an important uncertainty. What is the most appropriate MAH response process?

Provide an informal response from a single employee without documented review Identify the exact question, supporting evidence, responsible experts, review steps and final approved response Wait until the next PSUR because requests during assessment are administrative rather than scientific Submit the original PSUR conclusion again with no additional analysis

Question 8 of 10 Which completion criterion is most defensible for a PSUSA-related implementation action?

The responsible employee believes the task is complete The submission was sent to the authority The required regulatory outcome has been implemented as applicable, verified across affected systems or products and supported by retained evidence The procedure has been removed from the active tracker

Question 9 of 10 What is PRAC's role in an applicable PSUSA procedure?

PRAC prepares the PSUR on behalf of the MAH PRAC performs technical validation but does not assess safety evidence PRAC considers the scientific assessment and adopts a recommendation within its legal remit PRAC automatically issues the European Commission decision for every product

Question 10 of 10 Why is procedure closure not necessarily the same as pharmacovigilance action closure?

Regulatory procedures can never be formally closed Publication of an outcome may create continuing obligations such as variations, studies, risk minimisation or future reporting MAHs are required to keep every procedure open indefinitely Only the QPPV can close a regulatory procedure

GVP Module VII: PSUR Assessment, PRAC and Regulatory Follow-Up Knowledge Assessment

Cookie Settings